Julia Lawrence, D.O., Assistant Professor Internal Medicine-Hematology and Oncology

Julia Lawrence, D.O.

Associate Professor, Hematology & Oncology
Comprehensive Cancer Center

Clinical Specialties

Breast Cancer

Contact Information

New Patient Appointments: 336-716-WAKE
Returning Patient Appointments: 336-713-5440
Department: 336-716-4464

Email: jalawren@wakehealth.edu

Insurance Accepted »

Education & Training

B.A., New York University , 1985
D.O., New York College of Osteopathic Medicine , 1989
Residency, Internal Medicine, Med Coll Virginia Hosps, 1993
Fellowship, Medical Oncology, Natl Cancer Institute (NIH), 1996

Board Certifications

American Board of Internal Medicine, Internal Medicine

Memberships

Am Soc Of Clinical Oncology

NPI Number

1174534697

Julia Lawrence, D.O.

Associate Professor, Hematology & Oncology Comprehensive Cancer Center

Contact Information

Academic: 336-716-7251 | Department: 336-716-4464

Email: jalawren@wakehealth.edu

Recent Publications

Colonna SV, Case LD, Lawrence JA. A retrospective review of the metabolic syndrome in women diagnosed with breast cancer and correlation with estrogen receptor. Breast Cancer Res Treat. 2012;131(1):325-331.

Chotenimitkhun R, D'Agostino RB Jr, Lawrence JA, Hamilton CA, Jordan J, Vasu S, Lash TL, Hundley W. Preservation of left ventricular ejection fraction with statins during receipt of anthracycline based chemotherapy [abstract]. J Am Coll Cardiol. 2012;59(13 Suppl):E986.

Vern-Gross TZ, Lawrence JA, Case LD, McMullen KP, Bourland JD, Metheny-Barlow LJ, Ellis TL [deceased], Tatter SB, Shaw EG, Urbanic JJ, Chan MD. Breast cancer subtype affects patterns of failure of brain metastases after treatment with stereotactic radiosurgery. J Neurooncol. 2012;110(3):381-388.

Kimple RJ, Horton JK, Livasy CA, Shields JM, Lawrence JA, Chiu WM, Ivanova A, Ollila DW, Carey LA, Halle JS, Sartor CI, Dees EC. Phase I study and biomarker analysis of lapatinib and concurrent radiation for locally advanced breast cancer. Oncologist. 2012;17(12):1496-1503.

Vern-Gross TZ, McMullen KP, Case LD, Bourland JD, Ellis TL, Lawrence JA, Tatter SB, Shaw EG, Urbanic JJ, Chan MD. Patterns of failure in patients receiving gamma knife radiosurgery for breast carcinoma to the brain [abstract]. Int J Radiat Oncol Biol Phys. 2011;81(2 Suppl):S216-S217.

Vern-Gross TZ, McMullen KP, Case LD, Bourland JD, Ellis TL, Lawrence JA, Tatter SB, Shaw EG, Urbanic JJ, Chan MD. Patterns of failure in patients receiving gamma knife radiosurgery for breast carcinoma to the brain [abstract]. Neuro Oncol. 2011;13(Suppl 3):127.

Chaosuwannakit N, D'Agostino R Jr, Hamilton CA, Lane KS, Ntim WO, Lawrence J, Melin SA, Ellis LR, Torti FM, Little WC, Hundley WG. Aortic stiffness increases upon receipt of anthracycline chemotherapy. J Clin Oncol. 2010;28(1):166-172.

Russell SD, Blackwell KL, Lawrence J, Pippen JE Jr, Roe MT, Wood F, Paton V, Holmgren E, Mahaffey KW. Independent adjudication of symptomatic heart failure with the use of doxorubicin and cyclophosphamide followed by trastuzumab adjuvant therapy: a combined review of cardiac data. J Clin Oncol. 2010;28(21):3416-3421.

Klepin HD, Geiger AM, Costantino JP, Sink KM, Lawrence JA, Espeland MA. Association between domain-specific cognitive function and adherence to oral anti-cancer therapy: results from Cognition in the Study of Tamoxifen and Raloxifene (Co-STAR) [abstract]. J Am Geriatr Soc. 2010;58(Suppl 1):86-87.

Twomley K, D'Agostino R Jr, Lawrence J, Melin S, Ellis LR, Stacey B, Hamilton CA, Torti F, Little W, Hundley W. Early and persistent evidence of subclinical cardiovascular injury after receipt of anthracycline chemotherapy [abstract]. Circulation. 2010;122(21 Suppl):A12766.

Chaosuwannakit N, D'Agostino R Jr, Hamilton CA, Lane KS, Ntim WO, Lawrence J, Melin SA, Ellis LR, Torti FM, Little WC, Hundley WG. Subclinical cardiovascular toxicity of anthracyclines identified with cardiovascular magnetic resonance imaging [abstract]. Circulation. 2009;120(18 Suppl):S299.

Colonna S, Case D, Lawrence J. Correlation of the metabolic syndrome with estrogen receptor negative breast cancer in a retrospective review [abstract]. Cancer Res. 2009;69(24 Suppl 3):612S-613S.

Hemphill MB, Lawrence JA. Current therapeutic options for breast cancer central nervous system metastases. Curr Treat Options Oncol. 2008;9(1):41-50.